[European regulation on blood and blood components]

Area of Science:

• Public Health
• Regulatory Affairs
• Transfusion Medicine

Background:

• European Union (EU) blood and blood component regulations are established through four key directives.
• These directives aim to create a unified standard for blood quality and safety throughout EU Member States.
• Member states retain the ability to implement stricter protective measures.

Purpose of the Study:

• To outline the scope and impact of EU blood safety legislation.
• To highlight the comprehensive nature of the regulations, covering the entire blood supply chain.
• To emphasize the enhancement of haemovigilance systems.

Main Methods:

• Analysis of EU Directives 2002/98/EC, 2004/33/EC, 2005/61/EC, and 2005/62/EC.
• Review of provisions related to blood donor eligibility, collection, testing, processing, storage, transport, and distribution.
• Examination of haemovigilance requirements and their expansion.

Main Results:

• The EU regulations establish a common framework for blood quality and safety, benefiting all EU citizens.
• The directives encourage anonymous, voluntary, and unpaid blood donations.
• Haemovigilance systems have been expanded to include serious adverse events in the transfusion chain and reactions in blood donors.

Conclusions:

• The EU blood directives provide a robust legal basis for ensuring blood safety and quality.
• The legislation supports ethical donation practices and strengthens safety monitoring.
• Transposition into French national law occurred between 2004 and 2007.